[ 5/11 (Fri) ]
Precision Cancer Therapeutics


With the title of ‘Precision Cancer Therapeutics’, this session will provide an overview of the research trend in genome-based precision therapeutics. At the same time, this session will also provide an opportunity to expand global research network by engaging with global leaders in basic and clinical researches in precision therapeutics.


Representative Info. Sookyung Lee, Institute for Refractory Cancer Research, Samsung Medical Center, +82-2-2148-9775, sookyung0630.lee@samsung.com
Apply
Time Session Title
09 : 00 ~ 09 : 15 Opening Remarks, Welcome Address
09 : 15 ~ 10 : 00 [Keynote Speech] Evolution and drug responses in gliomas
Raul Rabadan, Columbia University
10 : 00 ~ 10 : 45 [Keynote Speech] A Novel Way to Control K-Ras-driven Cancer
Sung Hoon Kim, Seoul National University
10 : 45 ~ 11 : 00 Break
11 : 00 ~ 11 : 30 [Session I] Asian Project "Precision Medicine for HCC in the Asia-Pacific - the PLANET and PurPOSE Programs"
Pierce Chow, National Centre Singapore
11 : 30 ~ 12 : 00 [Session I] Asian Project "Precision Cancer Therapeutics - for Desperate Brain Cancer"
Danny Chan, The Chinese University of Hong Kong
12 : 00 ~ 13 : 30 Break
13 : 30 ~ 14 : 00 [Session Ⅱ] Drug Development "Development of Precision Cancer Immunotherapy: Opportunities and Challenges in Rapidly Evolving Landscape"
Su Youn Nam, INTS BIO
14 : 00 ~ 14 : 30 [Session Ⅱ] Drug Development "T Cell Exhaustion, Reinvigoration and Immuno-Oncology"
Eui-Cheol Shin, Korea Advanced Institute of Science and Technology
14 : 30 ~ 14 : 45 Break
14 : 45 ~ 15 : 15 [Session Ⅱ] Drug Development "CXCR4 hetromer as a drug target for precision cancer therapeutics"
Dong Seung Seen, GPCR
15 : 15 ~ 15 : 45 [Session Ⅱ] Drug Development "Therapeutic Development against Tumor Microenvironment Target."
Do-Hyun Nam, Samsung Medical Cente
15 : 45 ~ 16 : 00 Closing